Recurrent Fallopian Tube Transitional Cell Carcinoma
1 clinical trials · Condition
◉ Watch Recurrent Fallopian Tube Transitional Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents (NCT04739800) | National Cancer Institute (NCI) | 2021-06-10 |
Track Recurrent Fallopian Tube Transitional Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.